Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.850
-0.060 (-3.14%)
At close: Jan 23, 2026, 4:00 PM EST
1.836
-0.014 (-0.78%)
After-hours: Jan 23, 2026, 5:42 PM EST

Pulmonx Revenue

Pulmonx had revenue of $21.50M in the quarter ending September 30, 2025, with 5.47% growth. This brings the company's revenue in the last twelve months to $91.66M, up 15.59% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.

Revenue (ttm)
$91.66M
Revenue Growth
+15.59%
P/S Ratio
0.81
Revenue / Employee
$314,997
Employees
291
Market Cap
76.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray450.90M
Xtant Medical Holdings133.08M
Outset Medical120.07M
Sensus Healthcare35.61M
MaxCyte34.42M
electroCore29.84M
Spectral AI23.17M
Hyperfine10.59M
Revenue Rankings